These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 39005735)

  • 1. Design and Characterization of an Osmotic Pump System for Optimal Feeding and pH Control in
    Abedin S; Ranjbari J; Haeri A; Vahidi H; Moghimi HR
    Iran J Pharm Res; 2024; 23(1):e138677. PubMed ID: 39005735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Evaluation of a Once-Daily Controlled Porosity Osmotic Pump of Tapentadol Hydrochloride.
    Thakkar HP; Pancholi N; Patel CV
    AAPS PharmSciTech; 2016 Oct; 17(5):1248-60. PubMed ID: 26677859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and evaluation of controlled porosity osmotic pump for oral delivery of ketorolac.
    Dasankoppa FS; Ningangowdar M; Sholapur H
    J Basic Clin Pharm; 2012 Dec; 4(1):2-9. PubMed ID: 24808662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
    Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
    Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH; Taha NF; Badr RM; Mursi NM
    Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parallel substrate supply and pH stabilization for optimal screening of E. coli with the membrane-based fed-batch shake flask.
    Philip P; Kern D; Goldmanns J; Seiler F; Schulte A; Habicher T; Büchs J
    Microb Cell Fact; 2018 May; 17(1):69. PubMed ID: 29743073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and development of controlled porosity osmotic tablet of diltiazem hydrochloride.
    Shahi SR; Zadbuke NS; Gulecha B; Shivanikar SS; Shinde SB
    J Adv Pharm Technol Res; 2012 Oct; 3(4):229-36. PubMed ID: 23378944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of pore-formers and plasticizers on the release kinetic of diltiazem hydrochloride from the controlled porosity osmotic pumps.
    Shokri J; H Zarrintan M; Ghanbarzadeh S; Arash Z; Farahani A; Adibkia K
    Drug Res (Stuttg); 2013 Aug; 63(8):414-9. PubMed ID: 23599037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and in vitro/in vivo evaluation of etodolac controlled porosity osmotic pump tablets.
    Abd-Elbary A; Tadros MI; Alaa-Eldin AA
    AAPS PharmSciTech; 2011 Jun; 12(2):485-95. PubMed ID: 21479749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of microporous osmotic tablets of diltiazem hydrochloride.
    Bathool A; Gowda DV; Khan MS; Ahmed A; Vasudha SL; Rohitash K
    J Adv Pharm Technol Res; 2012 Apr; 3(2):124-9. PubMed ID: 22837961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation design and characterization of an elementary osmotic pump tablet of flurbiprofen.
    Patel KN; Mehta TA
    PDA J Pharm Sci Technol; 2014; 68(4):333-46. PubMed ID: 25035256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro-suspension coating method: a new approach in formulation and development of controlled porosity osmotic pump systems.
    Adibkia K; Hanaee J; Ghanbarzadeh S; Bahrami R; Shokri J
    Drug Res (Stuttg); 2014 Apr; 64(4):203-7. PubMed ID: 24026954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled porosity osmotic pump system with biphasic release of theophylline.
    Bi Y; Mao S; Gan L; Li Y; Wang C; Xu N; Zheng Y; Cheng Q; Hou S
    Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1574-80. PubMed ID: 17978514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel controlled porosity osmotic pump system for sodium ferulate.
    He L; Gong T; Zhao D; Zhang ZR; Li L
    Pharmazie; 2006 Dec; 61(12):1022-7. PubMed ID: 17283661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydration induced material transfer in membranes of osmotic pump tablets measured by synchrotron radiation based FTIR.
    Wu L; Yin X; Guo Z; Tong Y; Feng J; York P; Xiao T; Chen M; Gu J; Zhang J
    Eur J Pharm Sci; 2016 Mar; 84():132-8. PubMed ID: 26802550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine. I. Cellulose acetate as a semipermeable membrane.
    Makhija SN; Vavia PR
    J Control Release; 2003 Apr; 89(1):5-18. PubMed ID: 12695059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and optimization of buspirone oral osmotic pump tablet.
    Derakhshandeh K; Berenji MG
    Res Pharm Sci; 2014; 9(4):233-41. PubMed ID: 25657794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of controlled porosity osmotic pump for nifedipine and metoprolol combination.
    Kumaravelrajan R; Narayanan N; Suba V
    Lipids Health Dis; 2011 Apr; 10():51. PubMed ID: 21477386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an oral push-pull osmotic pump of fenofibrate-loaded mesoporous silica nanoparticles.
    Zhao Z; Wu C; Zhao Y; Hao Y; Liu Y; Zhao W
    Int J Nanomedicine; 2015; 10():1691-701. PubMed ID: 25784799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The delivery mechanism of micro-porous osmotic pump tablets].
    Zhao XL; Li Q; Gong XF; Li SM
    Yao Xue Xue Bao; 2007 Feb; 42(2):226-30. PubMed ID: 17518057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.